Clinical Trial Update: Initial Treatment of Patients With Immune Thrombocytopenic Purpura [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating initial treatment for Immune Thrombocytopenic Purpura was terminated, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenic Purpura

Snippet

Sponsor: Carelon Research | Conditions: Immune Thrombocytopenic Purpura | Phase 3 | Status: TERMINATED | Results posted: 2014-02-14